1. Singh A, Kumar A, Shankar S, Vashisht R, et al.
   Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man.
   AIDS 2022;36:1203-1204.
   


2. Zaccarelli M.
   How much do we need electronic clinical decision support systems to select patients to perform HIV tests in clinical settings?
   AIDS 2022;36:1201-1202.
   


3. Gharakhanian S, De Wit S.
   Hypogonadism in HIV infection: time to fine-tune clinical monitoring of persons with HIV?
   AIDS 2022;36:1197-1199.
   


4. Wood BR, Guthrie BL.
   Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial.
   AIDS 2022;36:1191-1193.
   


5. Lesko CR, Mugavero MJ, Shen NM, Fojo AT, et al.
   Exploring definitions of retention in care for people living with HIV in the United States in the modern treatment era.
   AIDS 2022;36:1181-1189.
   


6. Ignacio RAB, Shapiro AE, Nance RM, Whitney BM, et al.
   Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.
   AIDS 2022;36:1095-1103.
   


7. Smit M, Jordans CCE, Reinhard JM, Bramer WM, et al.
   Clinical decision support systems to guide healthcare providers on HIV testing.
   AIDS 2022;36:1083-1093.
   


8. Siddiqui M, Moore TJ, Long DM, Burkholder GA, et al.
   Risk factors for incident hypertension within one year of initiating antiretroviral therapy among people with HIV.
   AIDS Res Hum Retroviruses 2022.
   


9. Abidi SH, Siddiqui D, Mahmood SF, Siddiqui R, et al.
   Unassigned complex unique recombinant forms related to CRF36_cpx in children identified in an HIV-1 outbreak in Pakistan.
   AIDS Res Hum Retroviruses 2022.
   


10. Boateng AT, Abaidoo-Myles A, Bonney EY, Kyei GB, et al.
    Isoform selective versus non-selective histone deacetylase inhibitors in HIV latency reversal.
    AIDS Res Hum Retroviruses 2022.
    


11. Toeque MG, Lindsay B, Zulu PM, Hachaambwa L, et al.
    Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia.
    AIDS Res Hum Retroviruses 2022.
    


12. Lessard D, Dube K, Bilodeau M, Keeler P, et al.
    Willingness of older Canadians with HIV to participate in HIV cure research near and after the end-of-life: A mixed-method study.
    AIDS Res Hum Retroviruses 2022.
    


13. El Mikati IK, Khabsa J, Harb T, Khamis M, et al.
    A Framework for the Development of Living Practice Guidelines in Health Care.
    Ann Intern Med 2022.
    


14. Maponga TG, Jeffries M, Tegally H, Sutherland A, et al.
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis 2022.
    


15. Bradley H, Hall E, Asher A, Furukawa N, et al.
    Estimated number of people who inject drugs in the United States.
    Clin Infect Dis 2022.
    


16. Barre T, Moinot L, Spire B, Protopopescu C, et al.
    Integrating HIV-specific elements in the treatment of tobacco dependence.
    Clin Infect Dis 2022.
    


17. Marathe G, Moodie EE, Brouillette MJ, Delaunay CL, et al.
    Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada.
    Clin Infect Dis 2022.
    


18. Daniel Kelly J, Lu S, Anglin K, Garcia-Knight M, et al.
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis 2022.
    


19. Shah N, Esber A, Sean Cavanaugh J, Agaba P, et al.
    Transitioning women to first-line preferred TLD regimen is lagging in Sub-Saharan Africa.
    Clin Infect Dis 2022.
    


20. Ridolfi F, Peetluk L, Amorim G, Turner M, et al.
    TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
    Clin Infect Dis 2022.
    


21. Grudda T, Hwang HS, Taddese M, Quinn J, et al.
    Integrated hepatitis B virus DNA maintains surface antigen production during antivirals.
    J Clin Invest 2022.
    


22. Rogando AC, Weber KM, Xing J, Xue X, et al.
    The IDOze Study: The Link between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women with HIV.
    J Infect Dis 2022.
    


23. Cossu MV, Mileto D, Giacomelli A, Oreni L, et al.
    Does the co-morbidity burden contribute to suboptimal immunological responses to COVID-19 vaccination in people living with HIV?
    J Infect Dis 2022.
    


24. Berzosa Sanchez A, Epalza C, Navarro ML, Alcolea S, et al.
    SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid.
    Pediatr Infect Dis J 2022.
    

Display articles in

• Abstract format
• Medline format